SAN JOSE, Calif.--(BUSINESS WIRE)--DigitalOptics Corporation (DOC™), a wholly owned subsidiary of Tessera Technologies, Inc. (NASDAQ: TSRA) announced today that vivo COMMUNICATION TECHNOLOGY CO. LTD (vivo) has signed a multi-year license for DOC’s Face ToolsTM suite, which includes DOC’s industry leading Still and Video Face Beautification software. This software will be used in vivo smartphones.
“vivo is a smartphone brand leader in China and we are pleased to see them adopt our industry leading Face Beautification technologies,” said Jim Chapman, SVP Sales & Marketing of DOC. Smartphone end users in China demand portrait enhancement features. With DOC’s Face Beautification, we are able to provide the best in class solution that is consistent with the vivo brand promise.”
DOC’s FaceTools suite is also a key capability in its innovative microelectromechanical (MEMS) mems|cam™ mobile camera module. By combining FaceTools along with an extensive portfolio of market leading camera technologies, DOC will enable compelling new imaging features only available in mems|cam mobile camera modules for smartphone cameras.
Safe Harbor Statement
This document contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ significantly from those projected, particularly with respect to the impact and benefits of DOC’s agreement with vivo, market demands, and the features, benefits, characteristics and differentiated nature of DOC’s products, including FaceTools and mems|cam. Material factors that may cause results to differ from the statements made include the plans or operations relating to the Company’s businesses; market or industry conditions; changes in patent laws, regulation or enforcement, or other factors that might affect the Company’s ability to protect or realize the value of its intellectual property; the expiration of license agreements and the cessation of related royalty income; the failure, inability or refusal of licensees to pay royalties; initiation, delays, setbacks or losses relating to the Company’s intellectual property or intellectual property litigations, or invalidation or limitation of key patents; the timing and results, which are not predictable and may vary in any individual proceeding, of any ICC ruling or award, including in the Amkor arbitration; fluctuations in operating results due to the timing of new license agreements and royalties, or due to legal costs; the risk of a decline in demand for semiconductor and camera module products; failure by the industry to use technologies covered by the Company’s patents; the expiration of the Company’s patents; the Company’s ability to successfully complete and integrate acquisitions of businesses; the risk of loss of, or decreases in production orders from, customers of acquired businesses; financial and regulatory risks associated with the international nature of the Company’s businesses; failure of the Company’s products to achieve technological feasibility or profitability; failure to successfully commercialize the Company’s products; changes in demand for the products of the Company’s customers; limited opportunities to license technologies and sell products due to high concentration in the markets for semiconductors and related products and camera modules; the impact of competing technologies on the demand for the Company’s technologies and products; and the reliance on a limited number of suppliers for the components used in the manufacture of DOC products. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. The Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended Dec. 31, 2012, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2013, include more information about factors that could affect the Company’s financial results. The Company assumes no obligation to update information contained in this press release. Although this release may remain available on the Company’s website or elsewhere, its continued availability does not indicate that the Company is reaffirming or confirming any of the information contained herein.
About DigitalOptics Corporation
DigitalOptics Corporation (DigitalOptics or DOCTM), a wholly owned subsidiary of Tessera Technologies, Inc. (NASDAQ: TSRA), designs and manufactures innovative imaging systems for smartphones. The company leverages its deep expertise in optics, camera modules, MEMS and image processing to deliver pioneering products that expand the boundaries of smartphone photography. DOC’s mems|cam modules set the standard for camera module speed, size, power consumption, and precision. DigitalOptics is a leader in embedded image enhancement and computational photography algorithms, including its FaceToolsTM, HDR, panorama, multi-focus, and image stabilization products. DOC’s complementary suite of imaging solutions allows smartphone vendors to rapidly incorporate world-class cameras so users always have high-end imaging on hand. DigitalOptics is headquartered in San Jose, California. For more information visit www.doc.com
Tessera, Tessera, Inc., the Tessera logo, DOC, mems|cam, FaceTools, and Invensas Corporation are trademarks or registered trademarks of affiliated companies of Tessera Technologies, Inc. in the United States and other countries. All other company, brand and product names may be trademarks or registered trademarks of their respective companies.